Neue S3-Leitlinie Prostatakarzinom 2021 (Version6.2)– Was hat sich beim fortgeschrittenen Prostatakarzinom gendert?doi:10.1007/s00120-022-01927-zThere have been numerous new findings from clinical trials in recent years regarding the treatment of metastatic hormone-sensitive...
S3-Leitlinie: PSA-Bestimmung in der Prostatakarzinomdiagnostik (Früherkennung des Prostatakarzinoms). www.awmf-online.de. 2002 Google Scholar Flanigan RC, Catalona WJ, Richie JP et al. (1994) Accuracy of digital rectal examination and transrectal ultrasonography in localizing prostate cancer. J...
AWMF (2021) S3-Leitlinie Prostatakarzinom (Version 6.0). https://www.leitlinienprogramm- onkologie.de/leitlinien/prostatakarzinom/. Zuge- griffen: 17.06.2021 3. Barentsz JO, Richenberg J, Clements R, Choyke P, Verma S, Villeirs G, Rouviere O, Logager V, Fütterer JJ (2012) ESUR ...
Martin T, Wenz F, Bohmer D, Sedlmayer F, Hinkelbein W, Henkel TO, Miller K, Wiegel T (2010): Strahlentherapie des Prostatakarzinoms in der neuen S3-Leitlinie. Teil 2: Postoperative Strahlentherapie und Brachytherapie. Der Urologe 49, 216-220...
Neue S3-Leitlinie Prostatakarzinom 2021 (Version6.2)– Was hat sich beim fortgeschrittenen Prostatakarzinom gendert?doi:10.1007/s00120-022-01927-zProstate cancerSystemic therapyLocal therapyHormone-sensitiveCastration-resistantThere have been numerous new findings from clinical trials in recent years ...
Deutsche S3-LeitlinieThis report summarizes the relevant aspects of the S3 guideline prostate cancer for the radiation oncologist. Treatment decision and dose prescription are discussed, as well as technical performance of external beam radiotherapy and brachytherapy. The relevant literature is cited to ...